leg pain after semaglutide injection Wegovy® Site in the Thigh Ozempic reduces knee osteoarthritis pain

Goal setting: Establishing realistic and achievable health goals with your provider

At the end of the 24-week treatment period, the HA+semaglutide group experienced lower osteoarthritis pain scores and substantial improvements in knee function

It raises heart rate and blood pressure as secondary effects and is typically prescribed for short-term useusually 12 weeks or lessbecause tolerance develops and long-term safety data remain limited

Broadened Therapeutic Applications: Emerging evidence suggests that microdosing GLP-1 RAs might benefit conditions beyond diabetes and obesity, such as: Cognitive decline Arthritis Metabolic dysfunction Immune function Cardiovascular health Improved Cost-Effectiveness: Using less medication may lower treatment costs